Washington University in St. Louis at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Washington University in St. Louis brings 3 presentations to AMP 2026 in Seattle. Its sessions mix pathology education, on adapting communication for today's trainees, with circulating tumour DNA testing for measurable residual disease in solid tumours. It also brings WHO and ICC classification perspectives to a meet-the-authors session.
| Organization | AMP 2026 Attendance |
|---|---|
Washington University in St. Louis St. Louis, MO | |
Private research university in Missouri whose medical school runs genome sequencing and clinical molecular diagnostics programmes. | Talk Thu, Nov 12 7:15am–8:15am Adapting Communication Strategies for Today's Pathology Learners (A Special EdCoP Event) Teaching pathology trainees across generations and learning styles, including feedback and handling performance problems. Session Sat, Nov 14 10:15am–11:45am Update on the Role of CtDNA-Based Detection of MRD in Clinical Trials and Beyond for Solid Tumors
Workshop Sat, Nov 14 12:00pm–12:30pm AMP Innovates Meet the Authors Series: WHO/ICC Perspectives How genomic findings feed the WHO and ICC classifications of myeloid neoplasms, and what that means for treatment. |
Instantly find 20 buyers from Washington University in St. Louis
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction